Business
Everett Jolly, CEO of Uptick Newswire, Interviews CEO & Chairman of Blue Diamond Ventures on “Stock Day” Podcast
Everett Jolly, CEO of Uptick Newswire, Interviews CEO & Chairman of Blue Diamond Ventures on “Stock Day” Podcast.
About this update from Blue Diamond Ventures, Inc.
[{"type":"text","content":"\nPHOENIX, June 14, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire welcomed Josh Alper, CEO and Chairman of Blue Diamond Ventures, Inc. (OTC Pink:BLDV) (the “company”), onto the “Stock Day” podcast this week to discuss the company’s projects and provide financial updates.\n To start, “Stock Day” host Everett Jolly asked about the company’s reasons for the delay in their financial reporting, and an estimated timeline. Alper said that the company is in the process of bringing on a completely new financial team, relevant to their ongoing Can10 NA merger. Transitioning to a new accountant and a new attorney has delayed their financial reports, but everything should be settled and released by July 15th. “We’re systematically building relationships within the medical cannabis industry. As we do that, the merger with Can10 NA will allow us to take that next step financially,” Alper said. Blue Diamond Ventures, Inc. is initially focused on relationship building and consulting services with their clients. “Sometimes it looks like we’re doing a lot of projects,” said Alper when asked about their current endeavors taking place in California and Virginia. “But really, Can10 is the core relationship, the rest of the engagements are consulting projects where we bring expertise and intellectual property into the plan for potential licensing.” Alper also stresses the scientific aspects of the company, stating that they are first, and foremost science based, and science driven. Blue Diamond Ventures trades on the OTC Markets at a current price of 0.0006-0.0007 per share. One of the benefits of merging with Canada-based company Can10 North America, may be the ability to trade on the Canadian markets. Everett believes that their stock is extremely undervalued. “We do have a lot of respect for our shareholders,” said Alper, “and I know that it’s a difficult time for the stock, when we’re going through this transition. People are concerned because of what usually happens in the Pink Sheets… we’ve been at this for 2 years and we’ve demonstrated that we are not in it for short term financial gain. I want to reassure the shareholders that we are committed to creating long-term value for the stock.” To hear more...